We are live on ! Find out more
PTCT icon

PTC Therapeutics

84 hedge funds and large institutions have $601M invested in PTC Therapeutics in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

200% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 12

29% more funds holding

Funds holding: 6584 (+19)

0% more capital invested

Capital invested by funds: $600M → $601M (+$1.09M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
84
Holders Change
+19
Holders Change %
+29.23%
% of All Funds
2.41%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
27
Increased
36
Reduced
12
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BG
76
BlackRock Group
United Kingdom
$43K -$632K -29,538 -95%
U
77
UBS
Switzerland
$42K +$34.2K +1,598 New
PAM
78
Panagora Asset Management
Massachusetts
$34K -$1.28K -60 -4%
BJ
79
BlackRock Japan
Japan
$28K +$23.1K +1,080 New
Teacher Retirement System of Texas
80
Teacher Retirement System of Texas
Texas
$18K
BlackRock
81
BlackRock
New York
$14K +$4.75K +222 +74%
BNP Paribas Financial Markets
82
BNP Paribas Financial Markets
France
$5.46K +$2.25K +105 +101%
GSC
83
Ground Swell Capital
South Carolina
$3K +$2.14K +100 New
TRCT
84
Tower Research Capital (TRC)
New York
$1K +$792 +37 New
RCM
85
RA Capital Management
Massachusetts
-$25.7M -981,761 Closed
Jennison Associates
86
Jennison Associates
New York
-$22.5M -861,826 Closed
Loomis, Sayles & Company
87
Loomis, Sayles & Company
Massachusetts
-$12.4M -473,215 Closed
DM
88
Deerfield Management
New York
-$8.3M -317,530 Closed
Citadel Advisors
89
Citadel Advisors
Florida
-$3.21M -122,692 Closed
TC
90
TFS Capital
Pennsylvania
-$243K -9,289 Closed
SIM
91
Spark Investment Management
New York
-$203K -7,800 Closed
PC
92
Passport Capital
California
-$203K -7,755 Closed

PTCT Hedge Fund Activity: Q2 2014 in Review

84 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q2 2014, worth a combined $601M — up 0.18% from $600M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new PTCT positions and 8 closed out — a net gain of 19 holders — while 36 added to existing stakes and 12 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $12.9M. The largest seller was RA Capital Management, exiting entirely with an estimated $25.7M sold.

  • 84 institutional investors held PTC Therapeutics (PTCT) as of Q2 2014, up from 65 in Q1 2014.
  • Funds reported $601M of PTC Therapeutics stock for Q2 2014, up 0.18% quarter-over-quarter.
  • 27 funds opened new PTC Therapeutics positions in Q2 2014 and 8 closed out, a net change of +19 holders.
  • The largest PTC Therapeutics buyer in Q2 2014 was Sectoral Asset Management, an estimated $12.9M added.
  • The largest PTC Therapeutics seller in Q2 2014 was RA Capital Management, an estimated $25.7M sold.

Based on aggregated 13F filings for Q2 2014.